A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy
A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy
Recruiting · NCT06249438 · Registry updated 2025-07-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy | CNS demyelinating autoimmune disease, Neoplasms by Site, Paraneoplastic Syndromes, Nervous System, Skin and Connective Tissue Diseases, acute transverse myelitis, autoimmune disease, autoimmune disorder of the nervous system, connective tissue disorder, cranial nerve neuropathy, demyelinating disease, eye disorder, immune system disorder, multiple sclerosis, myasthenia gravis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, neuromyelitis optica, optic nerve disorder, optic neuritis, paraneoplastic syndrome, skin disorder, systemic lupus erythematosus, systemic sclerosis | Recruiting | Phase 1 | 2025-07-25 | NCT06249438 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AbelZeta Inc. | 4 |
| RenJi Hospital | 264 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Department of Rheumatology, RenJi Hospital, School of Medicine, Shanghai JiaoTong University | Shanghai | China | 1 |